Evidence map›Paper›PMID 38173392›Full record

ArticleHuman vaccines & immunotherapeutics2024

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?

Georgina Tzanakaki, Hana Cabrnochová, Snežana Delić, Anca Draganescu, Anna Hilfanova, Beáta Onozó, Marko Pokorn, Anna Skoczyńska, Goran Tešović

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 13 countries.

Georgina TzanakakiPublic Health Microbiology, National Meningitis Reference Laboratory, Laboratory for Surveillance of Infectious Diseases, Department of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
Hana CabrnochováCenter of children vaccination in Thomayer University Hospital, and Department of Pediatrics, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
Snežana DelićSerbian Reference Laboratory, Sombor, Serbia.
Anca DraganescuNational Institute for Infectious Diseases "Prof.Dr.Matei Bals", Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Anna HilfanovaDepartment of Pediatrics, Immunology, Infectious and Rare Diseases, European Medical School of the International European University, Kyiv, Ukraine.
Beáta OnozóPediatric Department of County Hospital, Miskolc, Hungary.
Marko PokornDivision of Paediatrics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Anna SkoczyńskaNational Reference Centre for Bacterial Meningitis, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
Goran TešovićUniversity of Zagreb, and Pediatric Infectious Diseases Department, University Hospital for Infectious Diseases, Zagreb, Croatia.
Carol Davila University of Medicine and Pharmacy · ROCharles University · CZEuropean University · UALaboratoire National de Référence · MALjubljana University Medical Centre · SINarodowy Instytut Leków · PLUniversity of Miskolc · HUUniversity of West Attica · GRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) is an acute life-threatening infection caused by the gram-negative bacterium,

Indexed as

Meningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisAdolescentChildCzech RepublicEuropeHumansInfantSerogroupVaccinationYoung AdultMeningococcal VaccinesAge distributionIMD epidemiologyimmunization programsinvasive meningococcal diseaseMenB vaccinesmeningococcal vaccinesquadrivalent vaccinesserogroup distributionSouth-Eastern Europevaccination policy

Identifiers

PMID38173392
PMCPMC10773623
OpenAlexW4390586364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.